Anil Namboodiripad
Corporate Officer/Principal bei DR. REDDY'S LABORATORIES LIMITED
Profil
Anil Namboodiripad is currently the Chief Executive Officer at SCRIPT Biosciences, Inc. since 2021.
He is also the Global Head-Proprietary Products at Dr. Reddy's Laboratories Ltd.
since 2016.
Dr. Namboodiripad holds a doctorate degree from The University of Texas at Austin.
Aktive Positionen von Anil Namboodiripad
Unternehmen | Position | Beginn |
---|---|---|
DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01.12.2016 |
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Chief Executive Officer | 01.01.2021 |
Ausbildung von Anil Namboodiripad
The University of Texas at Austin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Technology Services |